1. Regeneron starting late stage trials of coronavirus drug cocktail — Bristol-Myers pays Dragonfly Therapeutics $55M to bring NK cells to neuro diseases — JNJ in $480M-plus deal with Emergent for coronavirus vaccine supply — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

What about us in IT?

Discussion in 'Abbott IT' started by Anonymous, Apr 30, 2012 at 10:20 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Has anybody heard anything about us?
     

  2. Anonymous

    Anonymous Guest

    Yes. Add "SH" to your department name. That is what you have been and will be. Abbott IT has been terrible all these years and will probably continue to be terrible.
     
  3. Anonymous

    Anonymous Guest

    Yes, yes, yes! But it is our own damn fault! If we would pay to find the best, we could blow out the rest of the companies that are already hiring the best.
    Instead, what do we get? Contracted vendors that are just waiting to find a better gig at another company, not real Abbot employees.
    You get what you pay for.
     
  4. Anonymous

    Anonymous Guest

    No. You add misery to my each and every day. Our systems and support sucs in every way shape and form. The problem is that when decisions are made, Field personnel are not heavily involved as they should be. A few ball-less "yes" reps are brought in to nod their heads and say that everything is great.